Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optic nerve involvement in dysthyroidism.

J D Trobe

    Ophthalmology
    |June 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Graves' ophthalmopathy can cause optic neuropathy, a preventable cause of vision loss. Early diagnosis and treatment, including corticosteroids or surgery, can preserve sight.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Serous retinal detachment in hypertensive posterior reversible encephalopathy syndrome.

    AJNR. American journal of neuroradiology·2011
    Same author

    The Fifth European Neuro-Ophthalmological Society (EUNOS) meeting, Tübingen, Germany, July 22-26, 2001.

    Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2002
    Same author

    Penetrating orbital injury by automobile wiper-control stalk.

    Archives of ophthalmology (Chicago, Ill. : 1960)·2000
    Same author

    Common errors in the use of magnetic resonance imaging for neuro-ophthalmic diagnosis.

    Survey of ophthalmology·2000
    Same author

    Practice parameter: the role of corticosteroids in the management of acute monosymptomatic optic neuritis [RETIRED]. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

    Neurology·2000
    Same author

    Syndrome simulating pseudotumor cerebri caused by partial transverse venous sinus obstruction in metastatic prostate cancer.

    American journal of ophthalmology·2000
    Same journal

    Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

    Ophthalmology·2026
    Same journal

    Endocrine Mucin-Producing Sweat Gland Carcinoma of Eyelid.

    Ophthalmology·2026
    Same journal

    Multimodal Imaging of Optic Nerve Invasion in Unilateral Retinoblastoma.

    Ophthalmology·2026
    Same journal

    Avacincaptad Pegol Slows Progressive Ellipsoid Zone Degradation/Loss in Eyes With Geographic Atrophy.

    Ophthalmology·2026
    Same journal

    Access to Intravitreal Anti-VEGF Drugs in Persons with Medicare Advantage Compared with Medicare Fee-For-Service.

    Ophthalmology·2026
    Same journal

    Re: Dones et al.: Emergency department use of ocular point-of-care ultrasound and its utility in diagnosis at a tertiary academic medical center (Ophthalmology. 2026;133:720-727).

    Ophthalmology·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Endocrinology
    • Neurology

    Background:

    • Optic neuropathy is a rare but preventable cause of visual impairment in dysthyroidism (e.g., Graves' disease).
    • It often presents insidiously and bilaterally, masked by more apparent congestive signs.
    • Diagnosis requires suspicion based on characteristic adnexal changes and neuro-ophthalmic findings.

    Purpose of the Study:

    • To highlight the importance of recognizing and diagnosing optic neuropathy in dysthyroidism.
    • To discuss the pathogenesis and clinical presentation of dysthyroid optic neuropathy.
    • To review effective treatment strategies for this condition.

    Main Methods:

    • Review of clinical presentation and diagnostic criteria for dysthyroid optic neuropathy.
    • Analysis of the proposed mechanism involving apical orbital compression.
    • Evaluation of treatment outcomes with corticosteroids, irradiation, and surgery.

    Main Results:

    • Optic neuropathy prevalence in dysthyroidism is under 5% but leads to significant visual loss.
    • Neuro-ophthalmic signs are nonspecific, including visual field defects and optic nerve head changes (swollen or normal).
    • Treatment, particularly in early stages, shows beneficial effects.

    Conclusions:

    • Dysthyroid optic neuropathy is a critical, preventable cause of vision loss.
    • Suspect optic neuropathy in patients with dysthyroidism and relevant adnexal changes.
    • Prompt treatment, including corticosteroids, irradiation, or decompression, can improve visual outcomes.